EP3076962A4 - Modulation von ferroptose und behandlung von exzitotoxischen störungen - Google Patents
Modulation von ferroptose und behandlung von exzitotoxischen störungen Download PDFInfo
- Publication number
- EP3076962A4 EP3076962A4 EP14867950.9A EP14867950A EP3076962A4 EP 3076962 A4 EP3076962 A4 EP 3076962A4 EP 14867950 A EP14867950 A EP 14867950A EP 3076962 A4 EP3076962 A4 EP 3076962A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treating
- disorders
- modulating ferroptosis
- ferroptosis
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 231100000318 excitotoxic Toxicity 0.000 title 1
- 230000003492 excitotoxic effect Effects 0.000 title 1
- 230000004806 ferroptosis Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
- C07C2601/20—Systems containing only non-condensed rings with a ring being at least seven-membered the ring being twelve-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/72—Ethanonaphthalenes; Hydrogenated ethanonaphthalenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18168252.7A EP3384908B1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
EP20196973.0A EP3791870A1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361910580P | 2013-12-02 | 2013-12-02 | |
US201461948242P | 2014-03-05 | 2014-03-05 | |
PCT/US2014/067977 WO2015084749A1 (en) | 2013-12-02 | 2014-12-01 | Modulating ferroptosis and treating excitotoxic disorders |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18168252.7A Division EP3384908B1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
EP20196973.0A Division EP3791870A1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3076962A1 EP3076962A1 (de) | 2016-10-12 |
EP3076962A4 true EP3076962A4 (de) | 2017-10-18 |
Family
ID=53274009
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18168252.7A Active EP3384908B1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
EP20196973.0A Withdrawn EP3791870A1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
EP14867950.9A Withdrawn EP3076962A4 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18168252.7A Active EP3384908B1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
EP20196973.0A Withdrawn EP3791870A1 (de) | 2013-12-02 | 2014-12-01 | Modulation von ferroptose und behandlung von exzitotoxischen störungen |
Country Status (4)
Country | Link |
---|---|
US (2) | US10259775B2 (de) |
EP (3) | EP3384908B1 (de) |
AU (1) | AU2014357375B2 (de) |
WO (1) | WO2015084749A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822136B (zh) * | 2017-01-23 | 2019-06-21 | 冯世庆 | 一种化合物在修复神经损伤中的应用 |
JP7069295B2 (ja) | 2017-08-17 | 2022-05-17 | エックスダブリューファルマ リミテッド | 活性酸素種スカベンジャー誘導体の調製および使用 |
WO2019041361A1 (en) | 2017-09-04 | 2019-03-07 | Xw Laboratories, Inc. | PREPARATION AND USE OF A REACTIVE OXYGEN SPECIES TRAPPER |
MA52897A (fr) | 2018-06-15 | 2021-04-21 | Flagship Pioneering Innovations V Inc | Diminution de l'activité immunitaire par modulation de facteurs de signalisation post-cellulaire |
CN112638375A (zh) | 2018-06-15 | 2021-04-09 | 旗舰创业创新五公司 | 通过后细胞信号传导因子的调节来增加免疫活性 |
AU2019390478A1 (en) * | 2018-11-27 | 2021-07-08 | The Trustees Of Columbia University In The City Of New York | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders |
EP3931183A1 (de) * | 2019-02-27 | 2022-01-05 | Ferro Therapeutics, Inc. | Verbindungen mit ferroptose-induzierender aktivität und verfahren zu deren verwendung |
WO2021127217A1 (en) | 2019-12-17 | 2021-06-24 | Flagship Pioneering Innovations V, Inc. | Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
EP3915585A1 (de) | 2020-05-26 | 2021-12-01 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Therapeutische kombinationen mit ferroptose-agonisten zur behandlung proliferativer erkrankungen |
WO2023016447A1 (en) * | 2021-08-09 | 2023-02-16 | Sironax Ltd. | Ferroptosis modulators, preparations, and uses thereof |
CN114134197B (zh) * | 2021-12-09 | 2024-07-23 | 南京大学 | 一种基于荧光素酶报告基因的细胞毒性快速检测方法、细胞株的构建方法及其应用 |
US11541116B1 (en) | 2022-01-07 | 2023-01-03 | Kojin Therapeutics, Inc. | Methods and compositions for inducing ferroptosis in vivo |
CN114903997A (zh) * | 2022-07-13 | 2022-08-16 | 北京大学第三医院(北京大学第三临床医学院) | 铁死亡抑制剂在制备防治雄性生殖功能障碍的药物中的用途 |
CN116650451A (zh) * | 2023-06-13 | 2023-08-29 | 南通大学 | 白藜芦醇在制备肿瘤细胞铁死亡诱导剂中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0600832A1 (de) * | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Diaminobenzoe- und Diaminophthalsäurederivate und ihre Verfahren als Proteinkinase-Inhibitoren |
AU2001227084A1 (en) * | 2000-01-25 | 2001-08-07 | Japan Tobacco Inc. | N-arylhydrazide compounds and use thereof as drugs |
AU2002248180A1 (en) * | 2000-12-14 | 2002-07-16 | The Burnham Institute | Non-apoptotic forms of cell death and methods of modulation |
US20060142591A1 (en) * | 2004-10-25 | 2006-06-29 | Susan Lindquist | DAPH analogs and inhibition of protein aggregation |
WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
EP2388263A1 (de) | 2005-08-04 | 2011-11-23 | Sirtris Pharmaceuticals, Inc. | Imidazo[2,1-b]thiazol-Derivate als Sirtuin-Modulatoren |
US20070049565A1 (en) | 2005-08-24 | 2007-03-01 | Neurotech Pharmaceuticals Co., Ltd. | Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction |
US8030487B2 (en) * | 2006-07-07 | 2011-10-04 | Targegen, Inc. | 2-amino—5-substituted pyrimidine inhibitors |
WO2013152039A1 (en) * | 2012-04-02 | 2013-10-10 | The Trustees Of Columbia University In The City Of New York | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders |
-
2014
- 2014-12-01 WO PCT/US2014/067977 patent/WO2015084749A1/en active Application Filing
- 2014-12-01 US US15/100,967 patent/US10259775B2/en active Active
- 2014-12-01 EP EP18168252.7A patent/EP3384908B1/de active Active
- 2014-12-01 EP EP20196973.0A patent/EP3791870A1/de not_active Withdrawn
- 2014-12-01 AU AU2014357375A patent/AU2014357375B2/en active Active
- 2014-12-01 EP EP14867950.9A patent/EP3076962A4/de not_active Withdrawn
-
2019
- 2019-03-08 US US16/297,190 patent/US11192849B2/en active Active
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
US20190292135A1 (en) | 2019-09-26 |
EP3384908B1 (de) | 2020-09-30 |
AU2014357375B2 (en) | 2020-04-30 |
EP3384908A1 (de) | 2018-10-10 |
AU2014357375A1 (en) | 2016-07-07 |
US20160297748A1 (en) | 2016-10-13 |
US11192849B2 (en) | 2021-12-07 |
US10259775B2 (en) | 2019-04-16 |
WO2015084749A1 (en) | 2015-06-11 |
EP3076962A1 (de) | 2016-10-12 |
EP3791870A1 (de) | 2021-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3076962A4 (de) | Modulation von ferroptose und behandlung von exzitotoxischen störungen | |
EP3046470A4 (de) | Diagnose und behandlung von bewegungsstörungen | |
IL245733A0 (en) | aplnr modulators and their uses | |
EP3022705A4 (de) | Risikobewertung unter verwendung tragbarer vorrichtungen | |
EP2996595A4 (de) | Intervertebrale vorrichtungen und zugehörige verfahren | |
EP2973278A4 (de) | Sichere ferntransaktionen | |
EP3085355A4 (de) | Kosmetikum | |
EP3050043A4 (de) | Überwachung und behandlung von schlafstörungen | |
EP3011993A4 (de) | Applikator | |
IL283432A (en) | Preparations, methods and systems for the treatment of skin disorders | |
EP3041580A4 (de) | Systeme, vorrichtungen und verfahren für anti-tl1a-therapie | |
EP3082896A4 (de) | Dickdarmreinigungsvorrichtungen und verfahren | |
EP3075847A4 (de) | Transaminase und verwendung davon | |
HK1219823A1 (zh) | 易位調制系統、方法和設備 | |
EP3072554A4 (de) | Partikeltherapievorrichtung | |
EP3015480A4 (de) | Oberflächenbehandlungsmittel | |
EP3007756A4 (de) | Kathetergestützte tumorbehandlung | |
EP3021848A4 (de) | Behandlung von melanomen | |
EP3087056A4 (de) | Glucocerebrosidasemodulatoren und verwendungen davon | |
EP3057652A4 (de) | Vorrichtungen und verfahren zur stimulierung von nerven | |
EP3067088A4 (de) | Applikator | |
EP3052180A4 (de) | Antiseptischer applikator | |
EP3011992A4 (de) | Applikator | |
EP2968380A4 (de) | Verfahren und vorrichtungen zur beeinflussung der nervenfunktion | |
EP3007704A4 (de) | Kombinationstherapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160702 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 45/06 20060101ALI20170530BHEP Ipc: C07C 229/56 20060101ALI20170530BHEP Ipc: C07C 255/58 20060101ALI20170530BHEP Ipc: C07C 271/24 20060101ALI20170530BHEP Ipc: C07D 213/38 20060101ALI20170530BHEP Ipc: A61K 31/137 20060101ALI20170530BHEP Ipc: A61K 31/505 20060101ALI20170530BHEP Ipc: C07D 239/26 20060101ALI20170530BHEP Ipc: A61K 31/245 20060101AFI20170530BHEP Ipc: C07D 401/12 20060101ALI20170530BHEP Ipc: C07C 229/60 20060101ALI20170530BHEP Ipc: A61K 31/196 20060101ALI20170530BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170919 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/505 20060101ALI20170913BHEP Ipc: A61K 45/06 20060101ALI20170913BHEP Ipc: A61K 31/245 20060101AFI20170913BHEP Ipc: C07C 271/24 20060101ALI20170913BHEP Ipc: C07C 255/58 20060101ALI20170913BHEP Ipc: C07D 213/38 20060101ALI20170913BHEP Ipc: C07C 229/60 20060101ALI20170913BHEP Ipc: C07C 229/56 20060101ALI20170913BHEP Ipc: A61K 31/196 20060101ALI20170913BHEP Ipc: A61K 31/137 20060101ALI20170913BHEP Ipc: C07D 401/12 20060101ALI20170913BHEP Ipc: C07D 239/26 20060101ALI20170913BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20180420 |